Hala Shamsuddin

Statistics

Publications

Citations

2.3K

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Center for Drug Evaluation and Research

United States Food and Drug Administration

Hala Shamsuddin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, pharmacotherapy, and sars-cov-2 antiviral therapy.

Publications per year

2009–2023

Publications

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.9K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Scientific and Regulatory Reasons for Delay and Denial of FDA Approval of Initial Applications for New Drugs, 2000-2012

Leonard Sacks, Hala Shamsuddin, Yuliya Yasinskaya et al. · JAMA · 2014 · 214 citations

Pharmacy, Pharmaceutical Policy, Drug Approval Processes +13

Association Between Respiratory Disease in Hospitalized Patients and Periodontal Disease: A Cross‐Sectional Study

Nikhil Sharma, Hala Shamsuddin · Journal of Periodontology · 2011 · 87 citations

Dentistry, Periodontics, Periodontology +17

Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial

Matthew G. Johnson, Julie Strizki, Michelle Brown et al. · Infection · 2023 · 33 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Use of an active surveillance system by the FDA to observe patterns of quinine sulfate use and adverse hematologic outcomes in CMS Medicare data

Monika Houstoun, Marsha E. Reichman, David J. Graham et al. · Pharmacoepidemiology and Drug Safety · 2014 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–5 of 7